{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:57:46Z","timestamp":1762088266726,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2021R1A2C3004923"],"award-info":[{"award-number":["NRF-2021R1A2C3004923"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.steroids.2023.109257","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T21:56:28Z","timestamp":1686261388000},"page":"109257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Chenodeoxycholic acid regulates fibroblast growth factor 23 gene expression via estrogen-related receptor \u03b3 in human hepatoma Huh7 cells"],"prefix":"10.1016","volume":"197","author":[{"given":"Yiwen","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Seok","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon-Young","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalakannan","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hueng-Sik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.steroids.2023.109257_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/bj0890057","article-title":"The function of bile salts in fat absorption. The solvent properties of dilute micellar solutions of conjugated bile salts","volume":"89","author":"Hofmann","year":"1963","journal-title":"Biochem. J"},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Res."},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol. Cell"},{"issue":"13","key":"10.1016\/j.steroids.2023.109257_b0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.steroids.2023.109257_b0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.steroids.2023.109257_b0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","article-title":"Bile acids are nutrient signaling hormones","volume":"86","author":"Zhou","year":"2014","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.steroids.2023.109257_b0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","article-title":"Bile acid levels are increased in the liver of patients with steatohepatitis","volume":"20","author":"Aranha","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MOL.0000000000000597","article-title":"Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?","volume":"30","author":"Ch\u00e1vez-Talavera","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"10.1016\/j.steroids.2023.109257_b0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1620\/tjem.185.227","article-title":"Hepatic and serum bile acid compositions in patients with biliary atresia: a microanalysis using gas chromatography-mass spectrometry with negative ion chemical ionization detection","volume":"185","author":"Abukawa","year":"1998","journal-title":"Tohoku J. Exp. Med."},{"issue":"10215","key":"10.1016\/j.steroids.2023.109257_b0060","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.steroids.2023.109257_b0065","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"Goetz","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.steroids.2023.109257_b0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2012.07.002","article-title":"Fibroblast growth factor 23: state of the field and future directions","volume":"23","author":"Bhattacharyya","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.steroids.2023.109257_b0075","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.bone.2007.01.017","article-title":"Mineralized tissue cells are a principal source of FGF23","volume":"40","author":"Yoshiko","year":"2007","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.steroids.2023.109257_b0080","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cmet.2012.11.001","article-title":"Circulating fibroblast growth factors as metabolic regulators\u2014a critical appraisal","volume":"16","author":"Angelin","year":"2012","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13105-019-00675-7","article-title":"FGF19 subfamily members: FGF19 and FGF21","volume":"75","author":"Dolegowska","year":"2019","journal-title":"J. Physiol. Biochem."},{"issue":"15","key":"10.1016\/j.steroids.2023.109257_b0090","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1873-3468.13494","article-title":"Regulation of fibroblast growth factor 23 (FGF 23) in health and disease","volume":"593","author":"B\u00e4r","year":"2019","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0095","doi-asserted-by":"crossref","first-page":"E310","DOI":"10.1152\/ajpendo.00460.2012","article-title":"Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo","volume":"304","author":"Quinn","year":"2013","journal-title":"Am. J. Physiol.-Endocrinol. Metabol."},{"issue":"8","key":"10.1016\/j.steroids.2023.109257_b0100","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.steroids.2023.109257_b0105","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1210\/en.2013-1627","article-title":"Calcium regulates FGF-23 expression in bone","volume":"154","author":"David","year":"2013","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.steroids.2023.109257_b0110","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1359\/JBMR.050718","article-title":"Fibroblast growth factor-23 is regulated by 1\u03b1, 25-dihydroxyvitamin D","volume":"20","author":"Collins","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.steroids.2023.109257_b0115","doi-asserted-by":"crossref","unstructured":"O.I. Kolek, E.R. Hines, M.D. Jones, L.K. LeSueur, M.A. Lipko, P.R. Kiela, J.F. Collins, M.R. Haussler, F.K. Ghishan, 1\u03b1, 25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport, Am. J. Physiol.-Gastrointest. Liver Physiol. 289(6) (2005) G1036-G1042.","DOI":"10.1152\/ajpgi.00243.2005"},{"issue":"4","key":"10.1016\/j.steroids.2023.109257_b0120","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.steroids.2023.109257_b0125","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am. J. Physiol.-Renal Physiol."},{"issue":"6","key":"10.1016\/j.steroids.2023.109257_b0130","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.steroids.2023.109257_b0135","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","article-title":"Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism","volume":"18","author":"Kawata","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109257_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-05226-y","article-title":"The production of fibroblast growth factor 23 is controlled by TGF-\u03b22","volume":"7","author":"Feger","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.steroids.2023.109257_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/boneres.2016.11","article-title":"The hypoxia-inducible factor-1\u03b1 activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia","volume":"4","author":"Zhang","year":"2016","journal-title":"Bone Res."},{"key":"10.1016\/j.steroids.2023.109257_b0150","doi-asserted-by":"crossref","unstructured":"L. B\u00e4r, M. Feger, A. Fajol, L.-O. Klotz, S. Zeng, F. Lang, B. Hocher, M. F\u00f6ller, Insulin suppresses the production of fibroblast growth factor 23 (FGF23), Proc. Nat. Acad. Sci. 115(22) (2018) 5804-5809.","DOI":"10.1073\/pnas.1800160115"},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF 23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.steroids.2023.109257_b0160","doi-asserted-by":"crossref","unstructured":"E.G. Farrow, X. Yu, L.J. Summers, S.I. Davis, J.C. Fleet, M.R. Allen, A.G. Robling, K.R. Stayrook, V. Jideonwo, M.J. Magers, Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice, Proc. Nat. Acad. Sci. 108(46) (2011) E1146-E1155.","DOI":"10.1073\/pnas.1110905108"},{"issue":"5","key":"10.1016\/j.steroids.2023.109257_b0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.metabol.2016.02.009","article-title":"Exercise-stimulated FGF23 promotes exercise performance via controlling the excess reactive oxygen species production and enhancing mitochondrial function in skeletal muscle","volume":"65","author":"Li","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0170","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.steroids.2023.109257_b0175","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","article-title":"Bone as a source of FGF23: regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.steroids.2023.109257_b0180","doi-asserted-by":"crossref","unstructured":"K. Radhakrishnan, Y.-H. Kim, Y.S. Jung, D.-K. Kim, S.-Y. Na, D. Lim, D.H. Kim, J. Kim, H.-S. Kim, H.E. Choy, Orphan nuclear receptor ERR-\u03b3 regulates hepatic FGF23 production in acute kidney injury, Proc. Nat. Acad. Sci. 118(16) (2021) e2022841118.","DOI":"10.1073\/pnas.2022841118"},{"key":"10.1016\/j.steroids.2023.109257_b0185","article-title":"Acute liver injury induces expression of FGF23 in hepatocytes via orphan nuclear receptor ERR\u03b3 signaling","author":"Jung","year":"2022","journal-title":"Genes Dis."},{"issue":"6","key":"10.1016\/j.steroids.2023.109257_b0190","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.3892\/mmr.2015.3270","article-title":"Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats","volume":"11","author":"Ding","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.steroids.2023.109257_b0195","doi-asserted-by":"crossref","first-page":"e66182","DOI":"10.1371\/journal.pone.0066182","article-title":"Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list","volume":"8","author":"Pri\u00e9","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.steroids.2023.109257_b0200","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2147\/DMSO.S241348","article-title":"Association of serum fibroblast growth factor 23 levels with the presence and severity of hepatic steatosis is independent of sleep duration in patients with diabetes","volume":"13","author":"Hu","year":"2020","journal-title":"Diab. Metabol. Syndrom. Obes.: Targets Therapy"},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0205","doi-asserted-by":"crossref","first-page":"e0264743","DOI":"10.1371\/journal.pone.0264743","article-title":"Mouse liver injury induces hepatic macrophage FGF23 production","volume":"17","author":"Kumar","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0210","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4453","article-title":"Two case reports of FGF23-induced hypophosphatemia in childhood biliary atresia","volume":"138","author":"Wasserman","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.steroids.2023.109257_b0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7\u03b1-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.steroids.2023.109257_b0220","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M112.375907","article-title":"Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21","volume":"287","author":"Cyphert","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.steroids.2023.109257_b0225","doi-asserted-by":"crossref","first-page":"nrs. 05009","DOI":"10.1621\/nrs.05009","article-title":"The NR3B subgroup: an ovERRview","volume":"5","author":"Tremblay","year":"2007","journal-title":"Nucl. Recept. Signal."},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gene.2004.07.010","article-title":"Estrogen receptor-related receptor \u03b3 has an exceptionally broad specificity of DNA sequence recognition","volume":"340","author":"Razzaque","year":"2004","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0235","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1097-2765(02)00444-6","article-title":"Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3","volume":"9","author":"Greschik","year":"2002","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.steroids.2023.109257_b0240","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0006-291X(02)02753-5","article-title":"PGC-1 and PERC, coactivators of the estrogen receptor-related receptor \u03b3","volume":"299","author":"Hentschke","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0245","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1074\/jbc.M106140200","article-title":"Differential regulation of the orphan nuclear receptorsmall heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms","volume":"277","author":"Sanyal","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.steroids.2023.109257_b0250","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/JLB.2HI1219-762R","article-title":"Frontline Science: Estrogen-related receptor \u03b3 increases poly (I: C)-mediated type I IFN expression in mouse macrophages","volume":"109","author":"Kim","year":"2021","journal-title":"J. Leucocyte Biol."},{"issue":"26","key":"10.1016\/j.steroids.2023.109257_b0255","doi-asserted-by":"crossref","first-page":"21628","DOI":"10.1074\/jbc.M111.315168","article-title":"Orphan nuclear receptor estrogen-related receptor \u03b3 (ERR\u03b3) is key regulator of hepatic gluconeogenesis","volume":"287","author":"Kim","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.steroids.2023.109257_b0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm.3483","article-title":"Inverse agonist of estrogen-related receptor \u03b3 controls Salmonella typhimurium infection by modulating host iron homeostasis","volume":"20","author":"Kim","year":"2014","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.steroids.2023.109257_b0265","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1091\/mbc.10.11.3787","article-title":"Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress","volume":"10","author":"Haze","year":"1999","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.steroids.2023.109257_b0270","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/gutjnl-2012-303347","article-title":"Estrogen-related receptor \u03b3 controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol","volume":"62","author":"Kim","year":"2013","journal-title":"Gut"},{"issue":"17","key":"10.1016\/j.steroids.2023.109257_b0275","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137566","article-title":"ERR\u03b3 suppression by Sirt6 alleviates cholestatic liver injury and fibrosis","volume":"5","author":"Hao","year":"2020","journal-title":"JCI insight"},{"issue":"4","key":"10.1016\/j.steroids.2023.109257_b0280","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bmcl.2005.11.030","article-title":"Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERR\u03b3","volume":"16","author":"Chao","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.steroids.2023.109257_b0285","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/db12-0946","article-title":"Inverse agonist of nuclear receptor ERR\u03b3 mediates antidiabetic effect through inhibition of hepatic gluconeogenesis","volume":"62","author":"Kim","year":"2013","journal-title":"Diabetes"},{"issue":"42","key":"10.1016\/j.steroids.2023.109257_b0290","doi-asserted-by":"crossref","first-page":"28762","DOI":"10.1074\/jbc.M109.034165","article-title":"Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor \u03b3 transactivation","volume":"284","author":"Xie","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0295","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1042\/BJ20071637","article-title":"Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation","volume":"413","author":"Lee","year":"2008","journal-title":"Biochem. J"},{"issue":"11","key":"10.1016\/j.steroids.2023.109257_b0300","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3390\/ijms23116046","article-title":"Molecular Basis of Bile Acid-FXR-FGF15\/19 Signaling Axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.steroids.2023.109257_b0305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/JOE-17-0727","article-title":"FGF21 acts as a negative regulator of bile acid synthesis","volume":"237","author":"Chen","year":"2018","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109257_b0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1203\/00006450-199001000-00006","article-title":"Bone disease in chronic childhood cholestasis II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia","volume":"27","author":"Heubi","year":"1990","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.steroids.2023.109257_b0315","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/adc.54.5.367","article-title":"Serum 25-hydroxy-vitamin D in hepatobiliary disease in infancy","volume":"54","author":"Kobayashi","year":"1979","journal-title":"Arch. Dis. Child."},{"issue":"7","key":"10.1016\/j.steroids.2023.109257_b0320","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.steroids.2023.109257_b0325","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bone.2004.08.009","article-title":"Renal phosphate loss in hereditary and acquired disorders of bone mineralization","volume":"35","author":"Bielesz","year":"2004","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"White","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.steroids.2023.109257_b0335","doi-asserted-by":"crossref","unstructured":"J.L. Staudinger, B. Goodwin, S.A. Jones, D. Hawkins-Brown, K.I. MacKenzie, A. LaTour, Y. Liu, C.D. Klaassen, K.K. Brown, J. Reinhard, T.M. Willson, B.H. Koller, S.A. Kliewer, The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity, Proc. Nat. Acad. Sci. 98(6) (2001) 3369-3374.","DOI":"10.1073\/pnas.051551698"},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0340","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.steroids.2023.109257_b0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/MCB.20.1.187-195.2000","article-title":"The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: Two mechanisms for repression","volume":"20","author":"Lee","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"42","key":"10.1016\/j.steroids.2023.109257_b0350","doi-asserted-by":"crossref","first-page":"39411","DOI":"10.1074\/jbc.M106340200","article-title":"Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450","volume":"276","author":"Schuetz","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.steroids.2023.109257_b0355","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/hep.22712","article-title":"Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy","volume":"49","author":"Xing","year":"2009","journal-title":"Hepatology"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X23000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X23000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:10:21Z","timestamp":1758535821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X23000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":71,"alternative-id":["S0039128X23000855"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2023.109257","relation":{},"ISSN":["0039-128X"],"issn-type":[{"type":"print","value":"0039-128X"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chenodeoxycholic acid regulates fibroblast growth factor 23 gene expression via estrogen-related receptor \u03b3 in human hepatoma Huh7 cells","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2023.109257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109257"}}